v3.26.1
Segment Reporting - Summary of Significant Expenses and Other Segment Items (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
May 08, 2025
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Abstract]              
Revenues   $ 26,861   $ 20,018   $ 52,416 $ 37,976
Direct costs and expenses (less employee related expenses and depreciation and amortization)   3,540   3,050   6,252 5,573
Employee related expenses (less share-based compensation expenses)   19,420   16,966   38,629 31,770
Contracted services expenses   1,692   1,858   3,381 4,180
Sales and marketing education and event expenses   2,235   1,983   4,446 3,852
Occupancy and equipment service expenses   974   947   1,970 1,951
Clinical trials and associated costs   191   501   829 1,003
Depreciation and amortization expense   1,386   1,437   2,783 2,876
Share-based compensation expenses   820   1,039   1,935 2,011
Interest expense   1,982   1,898   3,959 3,583
Change in fair value of warrant liability, net $ 200     (98)     280
Other segment items   1,894   1,905   3,298 3,466
Net loss   $ (7,273) $ (7,793) $ (11,468) $ (11,101) $ (15,066) $ (22,569)